Prss16 is not required for T-cell development

Molecular and Cellular Biology

Volumn 25, Issue 2, 2005, Pages 789-796

  Cheunsuk, Saijai ^a   Lian, Zhe Xiong ^a   Yang, Guo Xiang ^a   Gershwin, M Eric ^a   Gruen, Jeffrey R ^b   Bowlus, Christopher L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SERINE PROTEASE PRSS 16; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DELETION MUTANT; EPITHELIUM CELL; FERTILITY; FETUS DEVELOPMENT; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE;

ANIMALS; CHIMERA; EPITHELIAL CELLS; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; SERINE ENDOPEPTIDASES; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMUS GLAND;

ANIMALIA;

EID: 11844287625     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.2.789-796.2005     Document Type: Article

References (33)

1. Anderson, G., and E. J. Jenkinson. 2001. Lymphostromal interactions in thymic development and function. Nat. Rev. Immunol. 1:31-40.
2. + thymocytes in vitro. J. Exp. Med. 179:2027-2031.
3. + T cells that are dependent on MHC class II-bound peptide-flanking residues. J. Immunol. 169:739-749.
4. Baldwin, K. K., B. P. Trenchak, J. D. Altman, and M. M. Davis. 1999. Negative selection of T cells occurs throughout thymic development. J. Immunol. 163:689-698.
5. Barton, G. M., and A. Y. Rudensky. 1999. Requirement for diverse, low-abundance peptides in positive selection of T cells. Science 283:67-70.
6. Berg, L. J., B. Fazekas de St. Groth, A. M. Pullen, and M. M. Davis. 1989. Phenotypic differences between αβ versus β T-cell receptor transgenic mice undergoing negative selection. Nature 340:559-562.
7. Bowlus, C. L., J. Ahn, T. Chu, and J. R. Gruen. 1999. Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus. Cell. Immunol. 196:80-86.
8. Carson, R. T., K. M. Vignali, D. L. Woodland, and D. A. Vignali. 1997. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7:387-399.
9. Cheunsuk, S, R. Sparks, J. K. Noveroske, T. Hsu, M. J. Justice, M. E. Gershwin, J. R. Gruen, and C. L. Bowlus. 2002. Expression, genomic structure and mapping of the thymus specific protease Prss16: a candidate gene for insulin dependent diabetes mellitus susceptibility. J. Autoimmun. 18:311-316.
10. Farr, A. G., D. J. Eisenhardt, and S. K. Anderson. 1986. Isolation of murine thymic epithelium and an improved method for its propagation in vitro. Anat. Rec. 216:85-94.
11. Fink, P. J., and M. J. Bevan. 1978. H-2 antigens of the thymus determine lymphocyte specificity. J. Exp. Med. 148:766-775.
12. + thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. Immunity 6:401-410.
13. Gapin, L., Y. Fukui, J. Kanellopoulos, T. Sano, A. Casrouge, V. Malier, E. Beaudoing, D. Gautheret, J. M. Claverie, T. Sasazuki, and P. Kourilsky. 1998. Quantitative analysis of the T cell repertoire selected by a single peptide-major histocompatibility complex. J. Exp. Med. 187:1871-1883.
14. - thymocytes. J. Autoimmun. 10:279-285.
15. Hammond, K. J., D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey. 2001. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167:1164-1173.
16. Hogquist, K. A., A. J. Tomlinson, W. C. Kieper, M. A. McGargill, M. C. Hart, S. Naylor, and S. C. Jameson. 1997. Identification of a naturally occurring ligand for thymic positive selection. Immunity 6:389-399.
17. Honey, K., K. Benlagha, C. Beers, K. Forbush, L. Teyton, M. J. Kleijmeer, A. Y. Rudensky, and A. Bendelac. 2002. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 3:1069-1074.
18. Kasai, M., E. Kominami, and T. Mizuochi. 1998. The antigen presentation pathway in medullary thymic epithelial cells, but not that in cortical thymic epithelial cells, conforms to the endocytic pathway. Eur. J. Immunol. 28: 1867-1876.
19. Kisielow, P., H. S. Teh, H. Bluthmann, and H. von Boehmer. 1988. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335:730-733.
20. Lie, B. A., L. M. Sollid, H. Ascher, J. Ek, H. E. Akselsen, K. S. Rønningen, E. Thorsby, and D. E. Undlien. 1999. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens 54:162-168.
21. Lie, B. A., J. A. Todd, F. Pociot, J. Nerup, H. E. Akselsen, G. Joner, K. Dahl-Jørgensen, K. S. Rønningen, E. Thorsby, and D. E. Undlien. 1999. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am. J. Hum. Genet. 64: 793-800.
22. Mizuochi, T., M. Kasai, T. Kokuho, T. Kakiuchi, and K. Hirokawa. 1992. Medullary but not cortical thymic epithelial cells present soluble antigens to helper T cells. J. Exp. Med. 175:1601-1605.
23. Nakagawa, T., W. Roth, P. Wong, A. Nelson, A. Farr, J. Deussing, J. A. Villadangos, H. Ploegh, C. Peters, and A. Y. Rudensky. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280:450-453.
24. Oukka, M., P. Andre, P. Turmel, N. Besnard, V. Angevin, L. Karlsson, P. L. Trans, D. Charron, B. Bihain, K. Kosmatopoulos, and V. Lotteau. 1997. Selectivity of the major histocompatibility complex class II presentation pathway of cortical thymic epithelial cell lines. Eur. J. Immunol. 27:855-859.
25. Robinson, J. H., and A. A. Delvig. 2002. Diversity in MHC class II antigen presentation. Immunology 105:252-262.
26. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458.
27. Sant'Angelo, D. B., E. Robinson, C. A. Janeway, Jr., and L. K. Denzin. 2002. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor. Eur. J. Immunol. 32:2510-2520.
28. Sant'Angelo, D. B., P. G. Waterbury, B. E. Cohen, W. D. Martin, L. Van Kaer, A. C. Hayday, and C. A. Janeway, Jr. 1997. The imprint of intrathymic self-peptides on the mature T cell receptor repertoire. Immunity 7:517-524.
29. Shi, G. P., R. A. Bryant, R. Riese, S. Verhelst, C. Driessen, Z. Li, D. Bromine, H. L. Ploegh, and H. A. Chapman. 2000. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191:1177-1186.
30. Tolosa, E., W. Li, Y. Yasuda, W. Wienhold, L. K. Denzin, A. Lautwein, C. Driessen, P. Schnorrer, E. Weber, S. Stevanovic, R. Kurek, A. Melms, and D. Bromme. 2003. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J. Clin. Investig. 112:517-526.
31. + T cells in H-2Ma0/0 mice. Immunity 7:187-195.
32. Villadangos, J. A., R. A. Bryant, J. Deussing, C. Driessen, A. M. Lennon-Dumenil, R. J. Riese, W. Roth, P. Saftig, G. P. Shi, H. A. Chapman, C. Peters, and H. L. Ploegh. 1999. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172:109-120.
33. + T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99:12287-12292.